Sarepta Therapeutics Schedules Third-Quarter Financial Results

• Sarepta Therapeutics will report third-quarter 2026 financial results Nov. 5, 2026, following the Nasdaq Global Market close.
• A conference call to discuss the results is scheduled for Nov. 5 at 4:30 p.m. ET.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sarepta Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261022410590) on October 22, 2026, and is solely responsible for the information contained therein.